Virus patient in drug trial left hospital "improving drastically"
Patients receiving remdesivir in the trial recovered 31% faster, and were slightly less likely to die than those getting a placebo.
Remdesivir
Remdesivir shows promise against COVID-19
The antiviral drug remdesivir has shown promise in treating the COVID-19 infection in hospitalized patients. Dr. Mark McClellan, a professor of Business, Medicine and Policy at Duke University and a former FDA commissioner, joins CBSN's Reena Ninan for a closer look at the drug.
Fauci optimistic about drug for COVID-19
Dr. Anthony Fauci, the nation's top infectious disease specialist, expressed optimism about research showing the antiviral drug remdesivir can help some hospitalized COVID-19 patients recover faster. CBS News White House correspondent Ben Tracy joins CBSN's Reena Ninan with more on the White House's reaction.
Federal social distancing guidelines expire
The social distancing guidelines set out by the White House expire April 30, while stay-at-home orders are still in effect in many states. CBS News chief Washington correspondent Major Garrett joins CBSN to talk about the latest in the pandemic response and other political headlines.
Fauci optimistic about remdesivir as treatment for COVID-19
The drug may shorten the duration of an infection in seriously ill patients, according to preliminary results from an international drug trial.
Trump and Fauci tout "positive effect" of remdesivir
President Trump on Wednesday says that federal guidelines to slow the spread of the coronavirus will not be extended when they expire at the end of the week. Dr. Anthony Fauci also announced the success of a trial of the drug remdesivir. Politico White House correspondent and associate editor Anita Kumar joins CBSN's Elaine Quijano to discuss the day's headlines.
Gilead stock jumps on hopes for COVID-19 treatment
Shares climb as much as 7% after company says experimental antiviral drug remdesivir helped patients if given early.
Gilead stock surges as market rallies behind remdesivir drug
Stocks spiked amid hopes the U.S. economy could reopen and promising early results for a remdesivir drug trial.
Patients rushing to join studies of promising coronavirus drug
Gilead Sciences' remdesivir is farther along in testing than many other potential therapies and the studies could lead to regulatory approval.
Shortage of possible coronavirus treatment puts others at risk
Drugs like remdesivir and hydroxychloroquine are in short supply. Patients who count on them to treat other conditions may not have access.
5 things you should know about coronavirus treatments
Malaria drugs chloroquine and hydroxychloroquine will be made available "almost immediately" to treat coronavirus patients. Here's what you need to know.
"There is hope": 2 drugs that could help patients fight the virus
CBS News medical contributor Dr. David Agus joined "CBS Evening News" to break down what we know.
Live
Iran's Houthi allies deny losing ground as Mideast crisis engulfs Yemen
Trump suggests letting Iran "take out" LA, San Diego during rally
Jim Bakker, who co-founded "The PTL Club" but fell into disgrace, dies at 86
Trump says he'll start paying for ads after pushback over taxpayer funding
Rubio calls on Russia to be more open about plague lab worker's death
Democrats see White House "pay for play" scheme with Balkan gas project
French high schools closed in biggest day of student protests in decades
Judge to weigh effort to deport Kilmar Abrego Garcia to Liberia
